Jove
Visualize
お問い合わせ

関連する概念動画

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Relative importance of blood-based biomarkers for Alzheimer's disease-specific neurodegeneration and cognitive decline.

The journal of prevention of Alzheimer's disease·2026
Same author

Reorganization of brain-autonomic integration in alcohol use disorder.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Fosfomycin as Oral Transition Therapy Versus Continued Intravenous β-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Quality of mental health care among insured patients in an Indonesian psychiatric hospital.

BMC health services research·2026
Same author

Performance and Cost-Efficiency of an MPT64 Assay for Detecting <i>Mycobacterium tuberculosis</i> Complex in a Setting With Frequent Nontuberculous Mycobacteria Isolation.

Journal of Korean medical science·2026
Same author

Clinical Approaches to <i>Clostridioides difficile</i> Infection Management: Insights From a Nationwide Survey of Korean Physicians.

Journal of Korean medical science·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K

臨床症状

Eun Jin Yoon1,2, Heejung Kim2,3, Jun-Young Lee2,3

  • 1Seoul National University, Seoul, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
まとめ

複数の行動症状を伴う記憶障害型軽度認知障害(aMCI)の患者は、特定の脳領域におけるアミロイド沈着の増加を示します。これは、より進行した疾患段階を示唆しており、リスク層化のために軽度行動障害(MBI)の評価の有用性を強調しています。

キーワード:
軽度認知障害行動症状アミロイド沈着脳画像疾患進行

さらに関連する動画

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

関連する実験動画

Last Updated: Jan 7, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.4K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from S&#233;zary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

6.1K

科学分野:

  • 神経科学
  • 神経学
  • 老年学

背景:

  • 以前の研究では、複数の軽度行動障害(MBI)領域症状を伴う記憶障害型軽度認知障害(aMCI)患者において、アルツハイマー病進行のリスクが高いことが示されていました。
  • 本研究では、MBIサブグループとaMCI個人における早期アミロイド沈着との関連を調査します。

研究 の 目的:

  • aMCI患者における特定のMBIサブグループが早期のアミロイドベータ(Aβ)沈着と関連しているかどうかを判断すること。
  • MBI、アミロイド負荷、およびaMCIにおける認知機能との関係を探求すること。

主な方法:

  • 121人のaMCI患者と23人の認知的に健常(CU)な個人が18F-フルルビタベン(FBB)PETスキャンを受けました。
  • MBIは変換アルゴリズムを使用して評価され、aMCI参加者は無症候性、情動調節障害、および複雑なグループに分類されました。
  • 年齢と性別を調整して、グループ間のFBB PET標準化取り込み値比(SUVR)マップのボクセルごとの比較を行いました。

主要な成果:

  • 複雑なMBI群は、CU個人と比較して、頭頂葉後部、下側頭葉、および角回皮質において、より高い領域FBB SUVRを示しました。
  • アミロイド陽性のaMCI患者は、無症候群群と比較して、より低い認知スコアを示しました。
  • MBIサブグループ間では、グローバルまたは領域アミロイド沈着に有意な差は見られませんでした。

結論:

  • aMCIにおける複数の併存MBI症状は、領域アミロイド沈着の増加および認知低下と関連しており、より進行した疾患段階を示唆しています。
  • MBI評価は、MCI患者のリスク層化に役立ちます。
  • これらの発見は、MCIにおける疾患進行の理解において行動症状の重要性を強調しています。